CanCan Body Composition Study
Part of paid clinical trials in Baton Rouge, Louisiana.
- Sponsor
- Pennington Biomedical Research Center
- Study ID
- NCT07305753
- Status
- Recruiting
Conditions
- Elderly (People Aged 65 or More)
- Healthy Participants
- Young Healthy Adults
Eligibility Criteria
- Sex
- ALL
- Age
- 20 Years - 90 Years
- Healthy Volunteers
- Accepted
Study Details
The aim of this study is to develop a dataset with reference body composition measurements using criterion methods. This dataset will be used to develop new protocols to study patients with cancer. Obtaining measurements of sodium bromide (NaBr), deuterium dilution (D2O), and D3-Creatine in a stratified sample of adults will determine the accuracy (and precision) of the available devices for ECW, TBW, and skeletal muscle mass measurements.
Key Dates
- First listed
- Dec 26, 2025
- Start date
- Oct 15, 2025
- Status verified
- Dec 2025
- Primary completion
- Apr 15, 2026
- Completion
- May 30, 2026
Study Design
- Enrollment
- 40 participants (estimated)
Arms
- Arm: Cross-sectional group20 young (20-40yo) and 20 older (70+) adults
Primary Outcome Measure
Skeletal Muscle Mass [ Time Frame: Single time point ]
Central Contacts
- Steven B Heymsfield, MD2257632541
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Pennington Biomedical Research Center | Baton Rouge | Louisiana | 70808 |
Find similar trials in Baton Rouge, LA
By research site
Related Studies
- A Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SR604 in Two Participants Groups (Part A: Healthy Participants, and Part B: Participants With Hemophilia A or Hemophilia B or Factor VII Deficiency)PHASE1 · Recruiting · Equilibra Bioscience LLC · Los Angeles, California
- FIH Study to Evaluate the Tolerability of PF-07832837 in Healthy Adults and PatientsPHASE1 · Recruiting · Pfizer · Anaheim, California
- A Study of Oral E1018 in Healthy Adult ParticipantsPHASE1 · Recruiting · Eisai Inc. · Austin, Texas
- A Study to Investigate the Safety and Pharmacokinetics of Single- and Multiple-ascending Doses of AZD4916 in Healthy VolunteersPHASE1 · Not Yet Recruiting · AstraZeneca · Glendale, California